González-García A, Norman FF, Gioia F, Patier de la Peña JL.

HIV positive male with an excrescent oral mass.

Revista clinica espanola 2014. 214(4): .

[doi:10.1016/j.rce.2014.01.017]

Yebra G, Delgado R, Pulido F, Rubio R, Galán JC, Moreno S, Holguín Á.

Different trends of transmitted HIV-1 drug resistance in Madrid, Spain, among risk groups in the last decade.

ARCHIVES OF VIROLOGY 2014. 159(5): 1079-1087. Nº de citas: 16

[doi:10.1007/s00705-013-1933-y]

Serrano-Villar S, Sainz T, Lee SA, Hunt PW, Sinclair E, Shacklett BL, Ferre AL, Hayes TL, Somsouk M, Hsue PY, Van Natta ML, Meinert CL, Lederman MM, Hatano H, Jain V, Huang Y, Hecht FM, Martin JN, McCune JM, Moreno S, Deeks SG.

HIV-Infected Individuals with Low CD4/CD8 Ratio despite Effective Antiretroviral Therapy Exhibit Altered T Cell Subsets, Heightened CD8+T Cell Activation, and Increased Risk of Non-AIDS Morbidity and Mortality

PLoS Pathogens 2014. 10(5): . Nº de citas: 537

[doi:10.1371/journal.ppat.1004078]

van Griensven J, Carrillo E, López-Vélez R, Lynen L, Moreno J.

Leishmaniasis in immunosuppressed individuals

CLINICAL MICROBIOLOGY AND INFECTION 2014. 20(4): 286-299. Nº de citas: 281

[doi:10.1111/1469-0691.12556]

Fortún J, Martín-Dávila P, Gómez-Mampaso E, González-García A, Barbolla I, Gómez-García I, Wikman P, Ortíz J, Navas E, Cuartero C, Gijón D, Moreno S.

Extra-pulmonary tuberculosis: differential aspects and role of 16S-rRNA in urine

INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE 2014. 18(4): 478-485. Nº de citas: 16

[doi:10.5588/ijtld.13.0555]

Gasch O, Camoez M, Dominguez MA, Padilla B, Pintado V, Almirante B, Martín-Gandul C, López-Medrano F, de Gopegui ER, Ramón Blanco J, García-Pardo G, Calbo E, Horcajada JP, Granados A, Jover-Sáenz A, Dueñas C, Pujol M.

Lack of association between genotypes and haematogenous seeding infections in a large cohort of patients with methicillin-resistant Staphylococcus aureus bacteraemia from 21 Spanish hospitals

CLINICAL MICROBIOLOGY AND INFECTION 2014. 20(4): 361-367. Nº de citas: 8

[doi:10.1111/1469-0691.12330]

Arnalich-Montiel F, Lumbreras-Fernández B, Martín-Navarro CM, Valladares B, Lopez-Velez R, Morcillo-Laiz R, Lorenzo-Morales J.

Influence of Acanthamoeba Genotype on Clinical Course and Outcomes for Patients with Acanthamoeba Keratitis in Spain

JOURNAL OF CLINICAL MICROBIOLOGY 2014. 52(4): 1213-1216. Nº de citas: 49

[doi:10.1128/JCM.00031-14]

Gutiérrez F, García L, Padilla S, Alvarez D, Moreno S, Navarro G, Gómez-Sirvent J, Vidal F, Asensi V, Masiá M.

Risk of clinically significant depression in HIV-infected patients: effect of antiretroviral drugs

HIV MEDICINE 2014. 15(4): 213-223. Nº de citas: 31

[doi:10.1111/hiv.12104]

Sainz T, Diaz L, Navarro ML, Rojo P, Blázquez D, Ramos JT, de José MI, Álvarez-Fuente M, Serrano-Villar S, Mellado MJ, Muñoz-Fernández MA.

Cardiovascular biomarkers in vertically HIV-infected children without metabolic abnormalities

ATHEROSCLEROSIS 2014. 233(2): 410-414. Nº de citas: 18

[doi:10.1016/j.atherosclerosis.2014.01.025]

Kamara DA, Ryom L, Ross M, Kirk O, Reiss P, Morlat P, Moranne O, Fux CA, Mocroft A, Sabin C, Lundgren JD, Smith CJ, D:A:D study Group.

Development of a definition for Rapid Progression (RP) of renal function in HIV-positive persons: the D: A: D study

BMC Nephrology 2014. 15: 51-51. Nº de citas: 11

[doi:10.1186/1471-2369-15-51]

Monge S, Guillot V, Alvarez M, Chueca N, Stella N, Peña A, Delgado R, Córdoba J, Aguilera A, Vidal C, García F.

Clinically Relevant Transmitted Drug Resistance to First Line Antiretroviral Drugs and Implications for Recommendations

PLoS One 2014. 9(3): . Nº de citas: 15

[doi:10.1371/journal.pone.0090710]

Ehehalt U, Schunk M, Jensenius M, van Genderen PJ, Gkrania-Klotsas E, Chappuis F, Schlagenhauf P, Castelli F, Lopez-Velez R, Parola P, Burchard GD, Cramer JP.

Leishmaniasis acquired by travellers to endemic regions in Europe: A EuroTravNet multi-centre study

Travel Medicine and Infectious Disease 2014. 12(2): 167-172. Nº de citas: 45

[doi:10.1016/j.tmaid.2013.12.003]

Patier de la Peña JL, González-García A, Prieto Pareja E, Norman FF, Rojas Marcos J, Benito Paniagua D.

Parsonage-Turner syndrome during the treatment of HIV/HHV8-related multicentric Castleman disease.

Revista clinica espanola 2014. 214(2): .

[doi:10.1016/j.rce.2013.11.009]

González-Castillo J, Martín-Sánchez FJ, Llinares P, Menéndez R, Mujal A, Navas E, Barberán J.

Guidelines for the management of community-acquired pneumonia in the elderly patient

Revista Espanola de Quimioterapia 2014. 27(1): 69-86. Nº de citas: 38

Balandin Moreno B, Fernández Simón I, Pintado García V, Sánchez Romero I, Isidoro Fernández B, Romera Ortega MA, Alcántara Carmona S, Pérez Redondo M, Galdos Anuncibay P.

Tigecycline therapy for infections due to carbapenemase-producing Klebsiella pneumoniae in critically ill patients

SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES 2014. 46(3): 175-180. Nº de citas: 35

[doi:10.3109/00365548.2013.861608]

Abad-Fernández M, Cabrera C, García E, Vallejo A.

Transient increment of HTLV-2 proviral load in HIV-1-co-infected patients during treatment intensification with raltegravir

JOURNAL OF CLINICAL VIROLOGY 2014. 59(3): 204-207. Nº de citas: 5

[doi:10.1016/j.jcv.2013.12.010]

Martinez-Perez A, Norman FF, Monge-Maillo B, Perez-Molina JA, Lopez-Velez R.

An approach to the management of Trypanosoma cruzi infection ( Chagas' disease) in immunocompromised patients

Expert Review of Anti-Infective Therapy 2014. 12(3): 357-373. Nº de citas: 17

[doi:10.1586/14787210.2014.880652]

Casado JL, Bañon S, Andrés R, Perez-Elías MJ, Moreno A, Moreno S.

Prevalence of causes of secondary osteoporosis and contribution to lower bone mineral density in HIV-infected patients

OSTEOPOROSIS INTERNATIONAL 2014. 25(3): 1071-1079. Nº de citas: 33

[doi:10.1007/s00198-013-2506-3]